Suchergebnisse - "Ma, Yinzhong"

PubPharm (21)

1

Obesity-induced blood-brain barrier dysfunction : phenotypes and mechanisms

enthalten in: Journal of neuroinflammation | 2024

von Feng, Z. | Fang, C. | Ma, Y. | +1

2

Integrated transcriptomic and proteomic profiling reveals the key molecular signatures of brain endothelial reperfusion injury

enthalten in: CNS neuroscience & therapeutics | 2024

von Ji, Y. | Chen, Y. | Tan, X. | +10

3

Advancing stroke therapy : A deep dive into early phase of ischemic stroke and recanalization

enthalten in: CNS neuroscience & therapeutics | 2024

von He, Q. | Wang, Y. | Fang, C. | +5

4

Advancing stroke therapy : A deep dive into early phase of ischemic stroke and recanalization

enthalten in: CNS Neuroscience & Therapeutics | 2024

von He, Q. | Wang, Y. | Fang, C. | +5

5

Integrated transcriptomic and proteomic profiling reveals the key molecular signatures of brain endothelial reperfusion injury

enthalten in: CNS Neuroscience & Therapeutics | 2024

von Ji, Y. | Chen, Y. | Tan, X. | +10

6

An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and reduces stroke patient-derived MMP-9 activity

enthalten in: Pharmacological research | 2023

von Ji, Y. | Gao, Q. | Ma, Y. | +9

7

Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC

enthalten in: Pharmacological research | 2023

von He, Q. | Ma, Y. | Fang, C. | +10

8

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy

enthalten in: Pharmacological research | 2022

von Ma, Y. | Chen, Z. | He, Q. | +6

9

APPLICATION OF LEVOFLOXACIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN PREPARING ANTI-CEREBRAL ISCHEMIA-REPERFUSION INJURY DRUGS OR HEALTH CARE PRODUCTS

enthalten in: Europäisches Patentamt | 2022

von CHANG JUNLEI | YANG SHILUN | MA YINZHONG | +1

10

Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease

enthalten in: Frontiers in pharmacology | 2022

von Dai, Z. | Hu, T. | Su, S. | +8